Using CRISPR to decipher whether gene variants lead to cancer
In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...
GEN8m
Combining Base and Prime Editing to Decipher Which Gene Variants Lead to Cancer
Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.
technologynetworks9h
CRISPR Tools Identify Gene Mutations That Drive Cancer
ETH Zurich researchers used combined CRISPR techniques to reveal unknown cancer-related mutations in the EGFR gene, ...
CRISPR technology reveals essential noncoding RNAs in the human genome
Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA ...
Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism
Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...
Gene therapy protects against motor neuron disease in rats
University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...
JD Supra2d
To Be Or Not To Be: Self-Revocation of Seminal European Patents Creates New Uncertainty In CRISPR IP Space
CVC’s opponents argued, and the Appeal Board appears to have agreed, that without knowledge of the PAM sequence and its ...
technologynetworks6d
Gene Repair via CRISPR May Trigger Unwanted Defects
The research team has now succeeded in using the CRISPR system to insert the missing letters in the right place. They ...
Business Insider1d
Positive Outlook on Crispr Therapeutics AG Driven by Strong Pricing and Strategic Partnerships
Crispr Therapeutics AG (CRSP) Company Description: CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform ...